Recombinant interleukin 2 monotherapy for classic Kaposi sarcoma.
Shibagaki
R
R
Department of Dermatology, Kyoto Prefectural University of Medicine, Japan.
Kishimoto
S
S
Takenaka
H
H
Yasuno
H
H
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000473:pathology
D007376:Interleukin-2; D011994:Recombinant Proteins